首页>
外国专利>
MICRORNA-BASED THERAPY TARGETED AGAINST LCP-1 POSITIVE CANCERS
MICRORNA-BASED THERAPY TARGETED AGAINST LCP-1 POSITIVE CANCERS
展开▼
机译:针对LCP-1阳性肿瘤的基于微小RNA的治疗
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to a panel of miRNAs comprising miR-16-5p, miR-23a-5p, miR-125b-5p, miR-145-5p, miR-146a-3p, miR-181c-5p, miR-218-5p, miR-495-3p, let-7b-5p, and further comprising one or more miRNAs selected from the group consisting of miR-30a-5p, miR-30b-5p, miR-30c-5p, miR-30d-5p, miR-30e-5p, miR-194-5p, miR-302a-3p, miR-302a-5p, miR-335-3p, miR-335-5p, miR-367- 3p, miR-373-3p, and miR-885-5p, and to extracellular vesicles (EVs), e.g. of stem cell origin, loaded with the panel of miRNAs. The present invention further provides the panel or EVs for use in a method of treating LCP-1 positive cancer in a patient.
展开▼